Biopharma Phase 3 clinical trials bring a myriad of challenges and learning opportunities, for which if we can proactively prepare, we’ll be better positioned to successfully meet the challenges and ensure we’re ready for our ultimate goal, which is commercialization. Phase 3 also introduces a number of other considerations beyond clinical development, such as preparing the rest of the business for potential product launch. This program is great to give you an advanced review of considerations before or during Biopharma Phase 3 clinical trials. Whether you’re in clinical development or another function, you will learn about one of the most critical milestones for Biopharma organizations.